Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?

被引:17
作者
Samalin, Ludovic [1 ]
Guillaume, Sebastien [2 ]
Courtet, Philippe [2 ]
Abbar, Mocrane [3 ]
Lancrenon, Sylvie [4 ]
Llorca, Pierre-Michel [1 ]
机构
[1] CHU Clermont Ferrand, Dept Adult Psychiat B, F-63000 Clermont Ferrand, France
[2] Univ Montpellier, Psychiat Emergency & Post Emergency Dept, CHU Montpellier, INSERM,U1061, Montpellier, France
[3] CHU Caremeau, Dept Adult Psychiat, Nimes, France
[4] Sylia Stat, Bourg La Reine, France
关键词
PSYCHIATRY WFSBP GUIDELINES; DOUBLE-BLIND; BIOLOGICAL TREATMENT; WORLD FEDERATION; MOOD STABILIZERS; ACUTE MANIA; DEPRESSION; PLACEBO; LAMOTRIGINE; EFFICACY;
D O I
10.1016/j.comppsych.2012.10.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Numerous guidelines for bipolar disorder have been published. The aim of this article is to underline the main differences between consensus-based guidelines (CBG) and evidence-based guidelines (EBG) currently available for the management of bipolar disorder. Methods: A literature search for guidelines published since 2006 was performed. A qualitative analysis was then conducted to compare the methodologies and the guidelines contents. Results: Comparison between CBG and EBG found more similarities than differences. However, discordances were found in the first-line choice of treatment (monotherapy or combination, use of lamotrigine or lithium in bipolar depression), time to reassessment and duration of maintenance treatment, introduction as from the acute phase a regimen compatible with long-term use and pharmacotherapy during pregnancy. Conclusions: The choice of policy, whatever the methodology used, is up to the authors and can, therefore, depend on their interpretation of the available scientific evidence. Combining both methodologies (CBG and EBG) enables us to meet the complete definition of evidence-based medicine. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 37 条
[1]  
[Anonymous], 2008, J Clin Psychiatry, V69, P1632
[2]   Antidepressant-Associated Mood Elevations in Bipolar II Disorder Compared With Bipolar I Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis [J].
Bond, David J. ;
Noronha, Melissa M. ;
Kauer-Sant'Anna, Marcia ;
Lam, Raymond W. ;
Yatham, Lakshmi N. .
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) :1589-1601
[3]  
Boutros N, 2012, YB INT PSYCHIAT BEHA
[4]   Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials [J].
Calabrese, Joseph R. ;
Huffman, Russell F. ;
White, Robin L. ;
Edwards, Suzanne ;
Thompson, Thomas R. ;
Ascher, John A. ;
Monaghan, Eileen T. ;
Leadbetter, Robert A. .
BIPOLAR DISORDERS, 2008, 10 (02) :323-333
[5]   A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, GS ;
Ascher, JA ;
Monaghan, E ;
Rudd, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :79-+
[6]  
Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18
[7]   A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders [J].
Frye, MA ;
Ketter, TA ;
Kimbrell, TA ;
Dunn, RT ;
Speer, AM ;
Osuch, EA ;
Luckenbaugh, DA ;
Corá-Locatelli, G ;
Leverich, GS ;
Post, RM .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (06) :607-614
[8]  
Frye MA, 2011, J CLIN PSYCHIAT, V72, P1295, DOI [10.4088/JCP.10123co1c, 10.4088/JCP.10123colc]
[9]   Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials [J].
Geddes, John R. ;
Calabrese, Joseph R. ;
Goodwin, Guy M. .
BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (01) :4-9
[10]   Antidepressants for bipolar depression: A systematic review of randomized, controlled trials [J].
Gijsman, HJ ;
Geddes, JR ;
Rendell, JM ;
Nolen, WA ;
Goodwin, GM .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (09) :1537-1547